These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3277664)
1. A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure. Duff GR; Graham PA Br J Ophthalmol; 1988 Jan; 72(1):27-8. PubMed ID: 3277664 [TBL] [Abstract][Full Text] [Related]
2. The 12-hour control of intraocular pressure on carteolol 2% twice daily. Duff GR; Newcombe RG Br J Ophthalmol; 1988 Dec; 72(12):890-1. PubMed ID: 3067744 [TBL] [Abstract][Full Text] [Related]
3. A double-masked comparison of carteolol and timolol in ocular hypertension. Scoville B; Mueller B; White BG; Krieglstein GK Am J Ophthalmol; 1988 Feb; 105(2):150-4. PubMed ID: 3277436 [TBL] [Abstract][Full Text] [Related]
4. A double-masked crossover study comparing the effects of carteolol 1% and 2% on intra-ocular pressure. Duff GR Acta Ophthalmol (Copenh); 1987 Oct; 65(5):618-21. PubMed ID: 3321878 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the ocular hypotensive efficacy and systemic safety of 0.5% levobunolol and 2% carteolol. Behrens-Baumann W; Kimmich F; Walt JG; Lue J Ophthalmologica; 1994; 208(1):32-6. PubMed ID: 8145982 [TBL] [Abstract][Full Text] [Related]
6. [Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops]. Flury H; Tournoux A; Martenet AC Klin Monbl Augenheilkd; 1986 Jun; 188(6):573-5. PubMed ID: 3761959 [TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. Trinquand C; Romanet JP; Nordmann JP; Allaire C; J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585 [TBL] [Abstract][Full Text] [Related]
8. [Carteolol: general practice-oriented assessment of the effectiveness and tolerance of a new beta-blocker in the treatment of glaucoma]. Schnaudigel OE; Becker H; Fuchs HB Klin Monbl Augenheilkd; 1988 Mar; 192(3):248-51. PubMed ID: 3374015 [TBL] [Abstract][Full Text] [Related]
9. Carteolol: preliminary study on ocular pressure-reducing action. Gorgone G; Spina F; Amantia L Ophthalmologica; 1983; 187(3):171-3. PubMed ID: 6355953 [TBL] [Abstract][Full Text] [Related]
10. [Aqueous humor flow measured by fluorophotometry. A comparative study of the effect of various beta-blocker eyedrops in patients with ocular hypertension]. Coulangeon LM; Sole M; Menerath JM; Sole P Ophtalmologie; 1990; 4(2):156-61. PubMed ID: 2235007 [TBL] [Abstract][Full Text] [Related]
11. [Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl)]. Kitazawa Y; Azuma I; Takase M; Komemushi S Nippon Ganka Gakkai Zasshi; 1981; 85(7):798-804. PubMed ID: 7030018 [No Abstract] [Full Text] [Related]
12. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product]. Yamamoto T; Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060 [TBL] [Abstract][Full Text] [Related]
13. [Effect of 0.004% travoprost and 2% carteolol on intraocular pressure in patients with ocular hypertension after laser peripheral iridotomy or trabeculectomy in primary angle-closure glaucoma]. Yao BQ; Pang YY; Li YX Zhonghua Yan Ke Za Zhi; 2013 Apr; 49(4):340-4. PubMed ID: 23900094 [TBL] [Abstract][Full Text] [Related]
14. [Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)]. Negishi C; Ueda S; Kanai A; Nakajima A; Funahashi M; Kitazawa Y; Komemushi S Nippon Ganka Gakkai Zasshi; 1981 Jan; 85(1):57-66. PubMed ID: 6114632 [No Abstract] [Full Text] [Related]